Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Corticotropin Patent Expiration

Corticotropin is used for promoting new vessel formation in ophthalmic diseases. It was first introduced by Sanofi Aventis Us Llc in its drug Acthar on Approved Prior to Jan 1, 1982. Other drugs containing Corticotropin are Acthar Gel (Autoinjector), Acthar Gel, Acth, Purified Cortrophin Gel, Corticotropin. 6 different companies have introduced drugs containing Corticotropin.


Corticotropin Patents

Given below is the list of patents protecting Corticotropin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Acthar Gel US11752199 Methods of modulating pericytes Feb 25, 2041 Mallinckrodt Ard
Purified Cortrophin Gel US11975047 Methods for storing and warming purified corticotropin compositions Oct 27, 2043 Ani Pharms



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Corticotropin Generics

Only one generic application has been filed for Corticotropin.

Given below is the list of companies who have filed for Corticotropin generic.


1. WATSON LABS

Watson Laboratories Inc has filed for 1 generic for Corticotropin. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40 UNITS/VIAL injectable Discontinued INJECTION N/A Nov 21, 1984